Approval-first for meningococcal vaccine
The first single vaccine to immunise against the five most…
The first single vaccine to immunise against the five most common meningococcal disease serogroups in adolescents has been approved in the US.
List view / Grid view
The first single vaccine to immunise against the five most…
The first single vaccine to immunise against the five most common meningococcal disease serogroups in adolescents has been approved in the US.
The US Food and Drug Administration (FDA) has authorised an…
The US Food and Drug Administration (FDA) has authorised an RSV vaccine for pregnant individuals, which in one study, reduced the risk of severe LRTD by 81.8 percent within 90 days after birth.